See more : Zillow Group, Inc. Class C (Z) Income Statement Analysis – Financial Results
Complete financial analysis of ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ZhuZhou QianJin Pharmaceutical Co.,Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Thor Industries, Inc. (0LF8.L) Income Statement Analysis – Financial Results
- Nera Telecommunications Ltd (N01.SI) Income Statement Analysis – Financial Results
- C5 Acquisition Corporation (CXAC-WT) Income Statement Analysis – Financial Results
- Volatus Capital Corp. (VC.CN) Income Statement Analysis – Financial Results
- Emerge Commerce Ltd. (EMCMF) Income Statement Analysis – Financial Results
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS)
About ZhuZhou QianJin Pharmaceutical Co.,Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd produces and sells pharmaceutical products in China. The company provides gynecology, pediatrics, beauty, antimicrobial, circulatory, endocrine, specialty, digestive, nervous, and cardiovascular products, as well as traditional Chinese medicines It offers its products in various forms, including tablets, capsules, granules, pills, decoctions, powders, and solution. The company also provides ginger tea; feminine hygiene products; and wine. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1993 and is headquartered in Zhuzhou, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.80B | 4.03B | 3.66B | 3.63B | 3.53B | 3.33B | 3.18B | 2.86B | 2.45B | 2.19B | 1.97B | 1.58B | 1.26B | 979.44M | 904.27M | 801.43M | 679.78M | 602.69M | 665.83M | 604.93M | 686.80M | 582.03M | 560.21M |
Cost of Revenue | 2.05B | 2.29B | 2.03B | 2.03B | 1.92B | 1.78B | 1.74B | 1.57B | 1.31B | 1.14B | 1.01B | 786.31M | 603.54M | 427.85M | 360.83M | 345.79M | 322.31M | 309.37M | 423.79M | 409.40M | 476.10M | 405.90M | 417.28M |
Gross Profit | 1.75B | 1.74B | 1.63B | 1.60B | 1.61B | 1.55B | 1.44B | 1.29B | 1.14B | 1.05B | 966.04M | 797.11M | 652.99M | 551.59M | 543.44M | 455.64M | 357.47M | 293.32M | 242.03M | 195.53M | 210.70M | 176.13M | 142.94M |
Gross Profit Ratio | 46.02% | 43.13% | 44.53% | 44.01% | 45.57% | 46.64% | 45.23% | 45.08% | 46.40% | 48.00% | 48.97% | 50.34% | 51.97% | 56.32% | 60.10% | 56.85% | 52.59% | 48.67% | 36.35% | 32.32% | 30.68% | 30.26% | 25.51% |
Research & Development | 149.07M | 113.82M | 108.72M | 104.06M | 105.36M | 84.09M | 67.00M | 61.86M | 64.69M | 48.23M | 36.79M | 32.98M | 14.64M | 10.61M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 63.89M | 67.65M | 74.99M | 69.79M | 55.81M | 41.77M | 43.72M | 41.38M | 38.27M | 33.89M | 31.45M | 31.14M | 26.73M | 20.06M | 71.00M | 59.10M | 54.29M | 57.58M | 49.12M | 44.37M | 43.65M | 37.31M | 29.03M |
Selling & Marketing | 569.15M | 911.58M | 888.30M | 894.86M | 938.86M | 994.17M | 942.52M | 861.90M | 801.83M | 724.88M | 624.39M | 508.75M | 428.56M | 379.74M | 321.08M | 275.45M | 221.32M | 173.99M | 124.44M | 98.61M | 94.70M | 77.73M | 61.07M |
SG&A | 1.18B | 979.23M | 963.29M | 964.64M | 994.67M | 1.04B | 986.24M | 903.28M | 840.10M | 758.77M | 655.84M | 539.89M | 455.29M | 399.80M | 392.08M | 334.54M | 275.62M | 231.57M | 173.56M | 142.99M | 138.35M | 115.04M | 90.10M |
Other Expenses | -47.51M | 218.61M | 189.11M | 156.08M | 147.75M | 14.91M | -9.71M | 13.56M | 14.95M | 10.55M | 3.72M | 726.27K | 1.61M | 8.09M | 1.66M | -1.13M | 133.04K | 1.24M | 1.31M | 1.76M | -801.33K | -938.57K | -1.96M |
Operating Expenses | 1.29B | 1.31B | 1.26B | 1.22B | 1.25B | 1.25B | 1.17B | 1.11B | 1.04B | 924.33M | 810.39M | 663.73M | 536.54M | 473.97M | 404.50M | 345.25M | 282.90M | 237.69M | 178.01M | 146.34M | 142.32M | 118.10M | 92.85M |
Cost & Expenses | 3.34B | 3.60B | 3.29B | 3.26B | 3.17B | 3.03B | 2.91B | 2.68B | 2.35B | 2.07B | 1.82B | 1.45B | 1.14B | 901.83M | 765.33M | 691.04M | 605.20M | 547.05M | 601.80M | 555.73M | 618.42M | 524.00M | 510.13M |
Interest Income | 51.39M | 9.76M | 11.95M | 30.37M | 38.61M | 20.87M | 11.75M | 10.89M | 4.61M | 1.25M | 230.71K | 1.68M | 4.09M | 1.58M | 0.00 | 1.91M | -0.09 | 2.36M | 1.78M | 3.68M | 1.94M | 1.58M | 1.71M |
Interest Expense | 5.96M | 2.21M | 2.11M | 2.25M | 416.40K | 747.26K | 2.59M | 2.85M | 6.52M | 6.14M | 4.15M | 2.14M | 186.79K | 80.69K | 0.00 | -345.00 | 724.11K | 1.05M | 139.15K | 1.18M | 2.26M | 1.08M | 276.78K |
Depreciation & Amortization | 103.65M | 112.40M | 102.16M | 76.77M | 70.49M | 66.43M | 66.12M | 53.54M | 50.37M | 48.47M | 48.25M | 40.02M | 38.28M | 35.97M | 25.22M | 21.77M | 20.91M | 24.26M | 23.33M | 21.99M | 18.33M | 13.06M | -1.89M |
EBITDA | 565.74M | 568.28M | 541.07M | 504.28M | 501.37M | 420.89M | 356.22M | 263.99M | 169.31M | 198.12M | 205.25M | 197.60M | 148.12M | 150.02M | 165.10M | 132.15M | 95.49M | 109.64M | 97.81M | 79.53M | 90.71M | 73.44M | 50.02M |
EBITDA Ratio | 14.89% | 13.62% | 13.20% | 13.36% | 13.38% | 12.54% | 11.08% | 9.21% | 6.94% | 8.84% | 10.77% | 11.80% | 12.78% | 15.19% | 18.26% | 22.60% | 11.77% | 18.19% | 14.69% | 13.15% | 13.21% | 12.62% | 8.93% |
Operating Income | 461.94M | 444.25M | 436.23M | 424.18M | 430.78M | 337.39M | 296.35M | 193.95M | 94.76M | 130.41M | 149.99M | 150.89M | 108.08M | 101.53M | 155.24M | 143.05M | 198.89M | 83.88M | 74.27M | 55.26M | 71.47M | 60.23M | 51.90M |
Operating Income Ratio | 12.16% | 11.03% | 11.91% | 11.70% | 12.22% | 10.14% | 9.31% | 6.77% | 3.87% | 5.94% | 7.60% | 9.53% | 8.60% | 10.37% | 17.17% | 17.85% | 29.26% | 13.92% | 11.15% | 9.13% | 10.41% | 10.35% | 9.26% |
Total Other Income/Expenses | -1.52M | 1.57M | -2.81M | 406.33K | -1.08M | 14.91M | -9.71M | 12.43M | 14.84M | 10.00M | 2.86M | 399.43K | 1.57M | 27.76M | 17.41M | 31.45M | 123.30M | 441.01K | 9.06M | 6.51M | -1.34M | -933.25K | -2.16M |
Income Before Tax | 460.42M | 445.81M | 433.42M | 424.58M | 429.70M | 352.30M | 286.64M | 206.38M | 109.60M | 140.42M | 152.85M | 151.29M | 109.65M | 109.54M | 156.06M | 141.83M | 197.87M | 84.32M | 74.33M | 56.36M | 70.12M | 59.29M | 49.74M |
Income Before Tax Ratio | 12.12% | 11.07% | 11.83% | 11.71% | 12.19% | 10.58% | 9.01% | 7.20% | 4.48% | 6.40% | 7.75% | 9.55% | 8.73% | 11.18% | 17.26% | 17.70% | 29.11% | 13.99% | 11.16% | 9.32% | 10.21% | 10.19% | 8.88% |
Income Tax Expense | 65.40M | 57.55M | 58.68M | 64.38M | 77.60M | 49.75M | 39.98M | 33.02M | 21.26M | 22.72M | 24.07M | 20.38M | 14.88M | 11.96M | 19.15M | 7.34M | 21.28M | 9.36M | 12.61M | 9.78M | 21.69M | 20.35M | 14.39M |
Net Income | 320.41M | 302.51M | 302.06M | 297.07M | 294.31M | 255.36M | 207.76M | 149.43M | 92.96M | 105.09M | 123.77M | 120.16M | 82.82M | 86.38M | 130.91M | 129.89M | 173.62M | 71.78M | 59.86M | 45.39M | 50.07M | 39.75M | 34.49M |
Net Income Ratio | 8.44% | 7.51% | 8.24% | 8.19% | 8.35% | 7.67% | 6.53% | 5.22% | 3.80% | 4.79% | 6.27% | 7.59% | 6.59% | 8.82% | 14.48% | 16.21% | 25.54% | 11.91% | 8.99% | 7.50% | 7.29% | 6.83% | 6.16% |
EPS | 0.76 | 0.73 | 0.72 | 0.71 | 0.70 | 0.61 | 0.50 | 0.36 | 0.24 | 0.29 | 0.34 | 0.33 | 0.23 | 0.24 | 0.36 | 0.36 | 0.47 | 0.30 | 0.14 | 0.11 | 0.18 | 0.13 | 0.11 |
EPS Diluted | 0.76 | 0.73 | 0.72 | 0.71 | 0.70 | 0.61 | 0.50 | 0.36 | 0.24 | 0.29 | 0.34 | 0.33 | 0.23 | 0.24 | 0.36 | 0.36 | 0.47 | 0.30 | 0.14 | 0.11 | 0.18 | 0.13 | 0.11 |
Weighted Avg Shares Out | 422.53M | 418.51M | 418.51M | 418.51M | 418.51M | 418.48M | 418.51M | 418.45M | 383.34M | 365.75M | 365.82M | 365.80M | 365.79M | 365.77M | 365.76M | 365.77M | 365.78M | 304.83M | 304.83M | 304.83M | 304.83M | 304.83M | 304.83M |
Weighted Avg Shares Out (Dil) | 422.53M | 418.51M | 418.51M | 418.51M | 418.51M | 418.48M | 418.53M | 418.47M | 383.34M | 365.75M | 365.82M | 365.80M | 365.79M | 365.77M | 365.76M | 365.77M | 365.78M | 304.83M | 304.83M | 304.83M | 304.83M | 304.83M | 304.83M |
Source: https://incomestatements.info
Category: Stock Reports